Clinical Trial Update: Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study. [Phase 2]

View source ↗

Summary

Phase 2, pilot randomized and double-blind trial evaluating the effectiveness of the dipeptide N(2)-L-Alanyl-L-Glutamine in trauma ICU patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Injury

Drugs mentioned

• Dipeptide N(2)-L-Alanyl-L-Glutamine (L-alanyl-L-glutamine dipeptide)

Snippet

Sponsor: Hospital Universitari Son Dureta | Conditions: Trauma ICU Patients | Phase 2 | Status: UNKNOWN